DOI: http://dx.doi.org/10.18203/2349-3291.ijcp20182537

Neonatal and maternal outcome in oligohydramnios: a prospective study

Rizwan Ahmar, Sadia Parween, Smita Kumari, Manish Kumar

Abstract


Background: Oligohydramnios presents a threat to the fetus and has been correlated with increased risk of intrauterine growth retardation, meconium aspiration syndrome, severe birth asphyxia, low APGAR scores and congenital abnormities. It is associated with perinatal morbidity and mortality and maternal morbidity in a significant number of cases. Therefore, early detection of oligohydramnios and its management is important. Aim of this study was to know the fetal and maternal outcome in oligohydramnios.

Methods: 90 patients in third trimester of pregnancy with Oligohydramnios were selected after satisfying inclusion and exclusion criteria. A detailed history and examination were done. All required investigation done. Oligohydramnios confirmed by measuring Amniotic fluid index (AFI).

Results: Mean maternal age-26.1 years. Incidence of oligohydramnios was more in primipara (64.4%) in our study. And operative morbidity was also more in primipara (51.7%). Most common cause of Oligohydramnios was idiopathic (44.44%). Operative morbidity was significantly higher in Non-reassuring FHR (80%) than reassuring FHR (32%). 7 patients (7.78%) were found with fetoplacental insufficiency on Doppler study.

Conclusions: Oligohydramnios is frequent occurrence and demands intensive fetal surveillance and proper antepartum and intrapartum care so that perinatal morbidity and mortality and maternal morbidity can be reduced.


Keywords


Amniotic fluid index, Maternal and fetal outcome, Oligohydramnios

Full Text:

PDF

References


Cunningham FG, Leveno KJ, Bloom SL. Williams obstetrics, 23rd edition; Ch 4, Mc Graw Hill; 2010:88.

Cunningham FG, Leveno KJ, Bloom SL. Williams obstetrics (22nd ed) Ch.21. New York: McGraw- Hill;2007

Kehl S, Schelkle A, Thomas A, Puhl A, Meqdad K, Tuschy B et al. Single deepest vertical pocket or amniotic fluid index as evaluation test for predicting adverse pregnancyoutcome (SAFE trial): a multicenter, open-label, randomized controlled trial. Ultrasound Obstet Gynecol. 2016;47(6):674-9.

Phelan JP, Smith CV, Broussard P, Small M. Amniotic fluid volume assessment using the four-quadrant technique in the pregnancy at 36-42 weeks gestation. J Reprod Med. 1987;32(7):540-2.

Moore TR. Clinical assessment of amniotic fluid. Clin Obstet Gynaecol. 1997 Jun;40(2):303-13.

Beall MH, van den Wijngaard JP, van Gemert MJ, Ross MG. Regulation of amniotic fluid volume. Placenta. 2007 Aug-Sep;28(8-9):824-32.

Patrelli TS, Gizzo S, Cosmi E, Carpano MG, Di Gangi S, Pedrazzi G et al. Maternal hydration therapy improves the quantity of amniotic fluid and the pregnancy outcome in third-trimester isolated oligohydramnios: a controlled randomized institutional trial. J Ultrasound Med. Feb 2012;31(2):239-44.

Sherer DM. A review of amniotic fluid dynamics and the enigma of isolated oligohydramnios. Am J Perinatol. 2002;19:253-66.

Chate P, Khatri M, Hariharan C. Pregnancy outcome after diagnosis of oligohydramnios at term. Int J Reprod Contracept Obstet Gynaecol. 2013;2(1):23-26.

Asnafi N, Bouzari Z, Mohammadnetadj M. Oligohydramnios and Pregnancy Outcome: Ten-Year Review. IBBJ Winter. 2015;1(1).

Jagatia k, Singh N, Patel S. Maternal and fetal outcome in oligohydramnios- Study of 100 case. Int J Med Sci Public Health. 2013;2(3):724-727.

Tajinder K, Ruchika S. Feto-maternal outcome in pregnancies with abnormal AFI. IOSR-JDMS. 2016;15(4):71-75.

Jagatia K, Singh N, Patel S. Maternal and fetal outcome in oligohydramnios-Study of 100 cases. Int J Med Sci Public Health. 2013;2:724-7.

Golan A, Lin G, Evron S, Arieli S, Niv D, David MP. Oligohydramnios: maternal complications and fetal outcome in 145 cases. Gynecol Obstet Invest. 1994;37(2):91-5.

Bansal D, Deodhar P. A clinical study of maternal and perinatal outcome in oligohydramnios. J Res Med Den Sci. 2015;3(4):312-6.

Sriya R, Singhai S. Perinatal outcome in patients with amniotic fluid index <5cm. J Obstet Gynaecol India. 2001;51:98-100.

Casey BM, McIntire DD, Bloom SL, Lucas MJ, Santos R, Twickler DM, et al. Pregnancy outcomes after antepartum diagnosis of oligohydramnios at or beyond 34 weeks’ of gestation. Am J Obstet Gynecol. 2000;182(4):909-12.

Jandial C, Gupta S, Sharma S, Gupta M. Perinatal (12) outcome after antepartum diagnosis of oligohydramnios at or beyond 34 weeks of gestation. JK Sci. 2007;9(4):213-14.

Clark SL, Sabey P, Jolley K. Nonstress testing with acoustic stimulation and amniotic fluid volume assessment: 5973 tests without unexpected fetal death. Am J Obstet Gynecol. 1989;160(3):694-7.

Hitschold T, Weiss E, Berle P, Muntefering H. Histologic placenta findings in prolonged pregnancy: correlation of placental retarded maturation, fetal outcome and Doppler sonographic findings in the umbilical artery. Z Geburtshilfe Perinatol. 1989;193(1):42-6.

Kwon JY, Kwon HS, Kim YH, Park YW. Abnormal Doppler Velocimetry is related to adverse perinatal outcome for borderline amniotic fluid index during third trimester. J Obstet Gynecol Res. 2006:32(6):545-49.

Manning FA, Hill LM, Platt LD. Qualitative amniotic fluid volume determination by ultrasound: Antepartum detection of intrauterine growth retardation. Am J Obstet Gynecol. 1981;139(3):254-8.

Johnson JM, Chauhan SP, Ennen CS, Niederhauser A, Magann EF. A comparison of 3 criteria of oligohydramnios in identifying peripartum complications: a secondary analysis. Am J Obstet Gynecol. 2007;197(2):207.e1-7.

Zhang J, Troendle J, Meikle S, Klebanoff MA, Rayburn WF. Isolated oligohydramnios is not associated with adverse perinatal outcome. BJOG. 2004;111(3):220-5.

Wolff F, Schaefer R. Oligohydramnios-perinatal complications and diseases in mother and child. Geburtshilfe Frauenheilkd. 1994;54(3):139-43.